▶ 調査レポート

注意欠陥多動性障害(ADHD)治療の世界市場

• 英文タイトル:Global Market Study on Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics: Increasing Production of Generic ADHD Drugs to Boost Market Growth

Persistence Market Researchが調査・発行した産業分析レポートです。注意欠陥多動性障害(ADHD)治療の世界市場 / Global Market Study on Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics: Increasing Production of Generic ADHD Drugs to Boost Market Growth / PMR2006004資料のイメージです。• レポートコード:PMR2006004
• 出版社/出版日:Persistence Market Research / 2020年4月
• レポート形態:英文、PDF、177ページ
• 納品方法:Eメール
• 産業分類:生命科学
• 販売価格(消費税別)
  Individual User(1名用)¥509,600 (USD4,900)▷ お問い合わせ
  Multi User(5名用)¥790,400 (USD7,600)▷ お問い合わせ
  Corporate User(企業用)¥1,102,400 (USD10,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、注意欠陥多動性障害(ADHD)治療の世界市場について調査・分析し、エグゼクティブサマリー、市場概要、主要市場動向、市場状況、市場背景、市場需要分析・予測、薬物種類別(覚醒剤、非興奮剤)分析、年齢別(小児・青年、成人)分析、流通経路別(病院薬局、専門クリニック、電子商取引)分析、地域別(北米、中南米、ヨーロッパ、アジア太平洋、中東・アフリカ)分析、競争分析、仮定、調査手法などを含め、以下の構成でお届けいたします。
・エグゼクティブサマリー
・市場概要
・主要市場動向
・市場状況
・市場背景
・市場需要分析・予測
・注意欠陥多動性障害(ADHD)治療の世界市場規模:薬物種類別(覚醒剤、非興奮剤)
・注意欠陥多動性障害(ADHD)治療の世界市場規模:年齢別(小児・青年、成人)
・注意欠陥多動性障害(ADHD)治療の世界市場規模:流通経路別(病院薬局、専門クリニック、電子商取引)
・注意欠陥多動性障害(ADHD)治療の世界市場規模:地域別(北米、中南米、ヨーロッパ、アジア太平洋、中東・アフリカ)
・競争分析
・仮定
・調査手法

Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market – Scope of the Report

Persistence Market Research (PMR) recently published a study on the global attention-deficit hyperactivity disorder (ADHD) therapeutics market. The study provides detailed assessment on key market dynamics, including the drivers, trends, opportunities restraints, and detailed information about the ADHD therapeutics market structure. The market study presents exclusive information about how the attention-deficit hyperactivity disorder therapeutics market will grow during the forecast period of 2020-2030.

Key indicators of market growth, which include Year-on-Year (Y-o-Y) growth of the market and compounded annual growth rate (CAGR) are explained in PMR’s study in a comprehensive manner. Other information includes market share analysis by region and by product type, which helps in the deep understanding of the market by researchers, suppliers, manufactures, and distributors. This information can help readers understand the quantitative growth prospects of the attention-deficit hyperactivity disorder therapeutics market during the forecast period.

The study is relevant for manufacturers, suppliers, distributors, and investors, and can help them in developing appropriate strategies to grow in the market. Business researcher, shareholders, industry experts can leverage the information and data presented in PMR’s study.

The study also includes statistics as well as facts related to macroeconomics factors that are impacting developments in the market. It also offers actionable insights based on the future trends in the attention-deficit hyperactivity disorder therapeutics market. Furthermore, small businesses and new entrants in the ADHD therapeutics market too can make use of the information presented in this study, based on which, they can make appropriate business decisions in order to gain momentum in the market.

Key Questions Answered in PMR’s ADHD Therapeutics Market Report

Which regions will continue to remain the most profitable regional markets for ADHD therapeutics market players?
Which factors will induce a change in the demand for ADHD therapeutics during the assessment period?
What are the different opportunities available for emerging players in the attention-deficit hyperactivity disorder therapeutics market?
How are supply-side and demand-side drivers impacting the ADHD therapeutics market?
How will changing trends impact the attention-deficit hyperactivity disorder therapeutics market?
How can market players capture the low-hanging opportunities in the ADHD therapeutics market in developed regions?
Which companies are leading the attention-deficit hyperactivity disorder therapeutics market?
What are the winning strategies of stakeholders in the ADHD therapeutics market to upscale their position in this landscape?
ADHD Therapeutics Market: Research Methodology

In PMR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the attention-deficit hyperactivity disorder therapeutics market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the attention-deficit hyperactivity disorder therapeutics market study include statistics from government healthcare organizations, medicines journals, research journals, press release, annual reports, white papers, directories, and databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the attention-deficit hyperactivity disorder therapeutics market, and makes PMR’s projection on the growth prospects of the ADHD therapeutics market more accurate and reliable.

レポート目次

1. Executive Summary

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Development Trends

4. Market Context

4.1. Value Chain Analysis

4.2. List of Drug Manufacturers & Distributers/Suppliers

4.3. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market – Product Overview

4.4. PEST Analysis

4.5. Key Regulations

4.6. Disease Epidemiology

5. Market Background

5.1. Macro-Economic Factors

5.2. Market Dynamics

5.2.1. Drivers

5.2.2. Restraints

5.2.3. Opportunity

6. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Demand (in Value or Size in US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

6.1. Historical Market Value (US$ Mn) Analysis, 2015-2019

6.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030

6.2.1. Y-o-Y Growth Trend Analysis

6.2.2. Absolute $ Opportunity Analysis

7. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Analysis 2015-2019 and Forecast 2020-2030, by Drug Type

7.1. Introduction / Key Findings

7.2. Historical Market Size (US$ Mn) Analysis By Drug Type, 2014 – 2018

7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Type, 2019 – 2029

7.3.1. Stimulants

7.3.1.1. Amphetamine

7.3.1.2. Methylphenidate

7.3.1.3. Dextroamphetamine

7.3.1.4. Dexmethylphenidate

7.3.1.5. Lisdexamfetamine dimesylate

7.3.2. Non-stimulants

7.3.2.1. Atomoxetine

7.3.2.2. Bupropion

7.3.2.3. Guanfacine

7.3.2.4. Clonidine

7.4. Market Attractiveness Analysis By Drug Type

8. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Analysis 2015-2019 and Forecast 2020-2030, by Age Group

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ Mn) Analysis By Age Group, 2014 – 2018

8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Age Group, 2019 – 2029

8.3.1. Paediatric and Adolescent

8.3.2. Adult

8.4. Market Attractiveness Analysis By Age Group

9. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Analysis 2015-2019 and Forecast 2020-2030, by Distribution Channel

9.1. Introduction / Key Findings

9.2. Historical Market Size (US$ Mn) Analysis By Age Group, 2014 – 2018

9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2019 – 2029

9.3.1. Hospital Pharmacies

9.3.2. Speciality Clinics

9.3.3. Retail Pharmacies

9.3.4. e-Commerce

9.4. Market Attractiveness Analysis By Age Group

10. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Analysis 2015-2019 and Forecast 2020-2030, by Region

10.1. Introduction

10.2. Historical Market Size (US$ Mn) Analysis By Region, 2014 – 2018

10.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 – 2029

10.3.1. North America

10.3.2. Latin America

10.3.3. Europe

10.3.4. Asia Pacific

10.3.5. MEA

10.4. Market Attractiveness Analysis By Region

11. North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Analysis 2015-2019 and Forecast 2020-2030

11.1. Introduction

11.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 – 2018

11.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 – 2029

11.3.1. By Country

11.3.1.1. U.S.

11.3.1.2. Canada

11.3.2. By Drug Type

11.3.3. By Age Group

11.3.4. By Distribution Channel

11.4. Market Attractiveness Analysis

11.4.1. By Country

11.4.2. By Drug Type

11.4.3. By Age Group

11.4.4. By Distribution Channel

12. Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Analysis 2015-2019 and Forecast 2020-2030

12.1. Introduction

12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 – 2018

12.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 – 2029

12.3.1. By Country

12.3.1.1. Brazil

12.3.1.2. Mexico

12.3.1.3. Rest of Latin America

12.3.2. By Drug Type

12.3.3. By Age Group

12.3.4. By Distribution Channel

12.4. Market Attractiveness Analysis

12.4.1. By Country

12.4.2. By Drug Type

12.4.3. By Age Group

12.4.4. By Distribution Channel

13. Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Analysis 2015-2019 and Forecast 2020-2030

13.1. Introduction

13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 – 2018

13.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 – 2029

13.3.1. By Country

13.3.1.1. U.K.

13.3.1.2. France

13.3.1.3. Germany

13.3.1.4. Italy

13.3.1.5. Spain

13.3.1.6. Russia

13.3.1.7. Rest of Europe

13.3.2. By Drug Type

13.3.3. By Age Group

13.3.4. By Distribution Channel

13.4. Market Attractiveness Analysis

13.4.1. By Country

13.4.2. By Drug Type

13.4.3. By Age Group

13.4.4. By Distribution Channel

14. Asia Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Analysis 2015-2019 and Forecast 2020-2030

14.1. Introduction

14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 – 2018

14.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 – 2029

14.3.1. By Country

14.3.1.1. Japan

14.3.1.2. China

14.3.1.3. India

14.3.1.4. Australia and New Zealand

14.3.1.5. ASEAN

14.3.1.6. Rest of APAC

14.3.2. By Drug Type

14.3.3. By Age Group

14.3.4. By Distribution Channel

14.4. Market Attractiveness Analysis

14.4.1. By Country

14.4.2. By Drug Type

14.4.3. By Age Group

14.4.4. By Distribution Channel

15. MEA Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Analysis 2015-2019 and Forecast 2020-2030

15.1. Introduction

15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 – 2018

15.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 – 2029

15.3.1. By Country

15.3.1.1. GCC Countries

15.3.1.2. South Africa

15.3.1.3. North Africa

15.3.1.4. Rest of MEA

15.3.2. By Drug Type

15.3.3. By Age Group

15.3.4. By Distribution Channel

15.4. Market Attractiveness Analysis

15.4.1. By Country

15.4.2. By Drug Type

15.4.3. By Age Group

15.4.4. By Distribution Channel

16. Competition Analysis

16.1. Competition Dashboard

16.2. Competition Deep Dive

16.2.1. Pfizer Inc.

16.2.1.1. Overview

16.2.1.2. Product Overview

16.2.1.3. Key Financial

16.2.1.4. Key Developments

16.2.1.5. Analyst Commentary

16.2.2. Eli Lilly and Company

16.2.2.1. Overview

16.2.2.2. Product Overview

16.2.2.3. Key Financial

16.2.2.4. Key Developments

16.2.2.5. Analyst Commentary

16.2.3. Novartis AG

16.2.3.1. Overview

16.2.3.2. Product Overview

16.2.3.3. Key Financial

16.2.3.4. Key Developments

16.2.3.5. Analyst Commentary

16.2.4. GlaxoSmithKline PLC

16.2.4.1. Overview

16.2.4.2. Product Overview

16.2.4.3. Key Financial

16.2.4.4. Key Developments

16.2.4.5. Analyst Commentary

16.2.5. Mallinckrodt Pharmaceuticals

16.2.5.1. Overview

16.2.5.2. Product Overview

16.2.5.3. Key Financial

16.2.5.4. Key Developments

16.2.5.5. Analyst Commentary

16.2.6. Hisamitsu Pharmaceutical Co., Inc.

16.2.6.1. Overview

16.2.6.2. Product Overview

16.2.6.3. Key Financial

16.2.6.4. Key Developments

16.2.6.5. Analyst Commentary

16.2.7. Johnson & Johnson

16.2.7.1. Overview

16.2.7.2. Product Overview

16.2.7.3. Key Financial

16.2.7.4. Key Developments

16.2.7.5. Analyst Commentary

16.2.8. UCB S.A.

16.2.8.1. Overview

16.2.8.2. Product Overview

16.2.8.3. Key Financial

16.2.8.4. Key Developments

16.2.8.5. Analyst Commentary

16.2.9. Purdue Pharma L.P.

16.2.9.1. Overview

16.2.9.2. Product Overview

16.2.9.3. Key Financial

16.2.9.4. Key Developments

16.2.9.5. Analyst Commentary

17. Assumptions and Acronyms Used

18. Research Methodology

List of Tables

Table 01: Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Drug Type

Table 02: Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Age Group

Table 03: Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Distribution Channel

Table 04: Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Region

Table 05: North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Drug Type

Table 06: North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, by Age Group

Table 07: North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Distribution Channel

Table 08: North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, by Country

Table 09: Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Drug Type

Table 10: Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, by Age Group

Table 11: Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Distribution Channel

Table 12: Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, by Country

Table 13: Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Drug Type

Table 14: Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, by Age Group

Table 15: Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Distribution Channel

Table 16: Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, by Country

Table 17: Asia Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Drug Type

Table 18: Asia Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, by Age Group

Table 19: Asia Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Distribution Channel

Table 20: Asia Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, by Country

Table 21: MEA Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Drug Type

Table 22: MEA Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, by Age Group

Table 23: MEA Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Distribution Channel

Table 24: MEA Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, by Country